ClinicalTrials.Veeva

Menu

Effectiveness of a Natural Ingredient on Appetite Regulation (SAC)

U

Universidad Católica San Antonio de Murcia

Status

Completed

Conditions

Overweight and Obesity
Appetite Regulation

Treatments

Dietary Supplement: Dietary supplement consumption

Study type

Interventional

Funder types

Other

Identifiers

NCT04345029
UCAMCFE-00012

Details and patient eligibility

About

Single-center, double-blind, double-crossed, randomized controlled clinical trial with two crossed branches, designed with the objective of evaluating the effect of the investigational product on satiety.

Full description

Subjects who meet the selection criteria will make a total of five visits to the research laboratory and will carry out the tests established in the protocol. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain results.

Enrollment

36 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-65 years.
  • Both genders.
  • BMI 25-34.9 kg / m2, both inclusive.
  • Weight maintained during the last 3 months.
  • Smoking subjects or not, but in any case they do not change their nicotinic habits during their participation in the study.
  • Absence of disease diagnosed at the start of the study.

Exclusion criteria

  • Thyroid dysfunction, infections, or with any type of chronic disease (eg, autoimmune, inflammatory).
  • History of allergic hypersensitivity or poor tolerance to any component of the products under study.
  • Subjects who are performing or intend to carry out any type of diet, low-calorie or not, during the study.
  • Participation in another clinical trial in the three months prior to the study.
  • Lack of will or inability to comply with clinical trial procedures.
  • Pregnant woman.
  • Subjects whose condition does not make them eligible for the study according to the researcher's criteria.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

36 participants in 2 patient groups, including a placebo group

Experimental group (Lippia citriodora + sabdariffa)
Experimental group
Description:
Consumption for 60 days of Lippia citriodora 325 mg + Hibiscus sabdariffa 175 mg. Two capsules per day will be consumed thirty minutes before breakfast orally for 60 days.
Treatment:
Dietary Supplement: Dietary supplement consumption
control group Placebo (sucrose)
Placebo Comparator group
Description:
Two capsules per day will be consumed thirty minutes before breakfast orally for 60 days.
Treatment:
Dietary Supplement: Dietary supplement consumption

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems